{"id":165646,"date":"2024-03-19T19:59:12","date_gmt":"2024-03-19T18:59:12","guid":{"rendered":"https:\/\/rtvnp.rs\/?p=165646"},"modified":"2024-03-19T19:59:12","modified_gmt":"2024-03-19T18:59:12","slug":"nove-terapije-za-rak-dojke-uskoro-u-srbiji","status":"publish","type":"post","link":"https:\/\/arhiva.rtvnp.rs\/?p=165646","title":{"rendered":"Nove terapije za rak dojke uskoro u Srbiji"},"content":{"rendered":"<p class=\"p1\"><span class=\"s1\">Najkasnije do juna bi\u0107e dostupni inovativni likekovi kojim se od raka dojke lije\u010de \u00a0\u017eene u evropskim zemljama.<\/span>Rak dojke predstavlja naj\u010de\u0161\u0107e maligno oboljenje u razvijenijim zemljama svijeta, kao i u Srbiji.<\/p>\n<p class=\"p1\"><span class=\"s1\">Na nivou Srbije od karcinoma dojke oboli oko 4.500 \u017eena, ali da je pozitivno \u0161to se smrtnost iz godine u godinu smanjuje.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Najkasnije do juna bi\u0107e dostupni inovativni likekovi kojim se od raka dojke lije\u010de \u00a0\u017eene u evropskim zemljama.Rak dojke predstavlja naj\u010de\u0161\u0107e maligno oboljenje u razvijenijim zemljama svijeta, kao i u Srbiji. Na nivou Srbije od karcinoma dojke oboli oko 4.500 \u017eena, ali da je pozitivno \u0161to se smrtnost iz godine u godinu smanjuje.<\/p>\n","protected":false},"author":21,"featured_media":31588,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-165646","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-drustvo"],"_links":{"self":[{"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/posts\/165646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=165646"}],"version-history":[{"count":0,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/posts\/165646\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/media\/31588"}],"wp:attachment":[{"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=165646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=165646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=165646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}